YD Bio (YDESW) Goodwill & Intangibles (2024 - 2026)
YD Bio's (YDESW) quarterly Goodwill & Intangibles came in at $2.5 million in Q2 2026, down 14.75% year-over-year from $2.9 million in Q2 2025, and down 5.21% quarter-over-quarter from $2.6 million in Q4 2025.
Analysis
YD Bio (YDESW) Goodwill & Intangibles (2024 - 2026) Analysis & Trends
YD Bio (YDESW) has reported Goodwill & Intangibles for 3 consecutive years, with $2.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Goodwill & Intangibles fell 14.75% year-over-year to $2.5 million in Q2 2026; TTM through Jun 2026 was $2.5 million, a 14.75% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, down 2.62% from the prior year.
- Goodwill & Intangibles was $2.5 million for Q2 2026 at YD Bio, down from $2.6 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $2.9 million in Q2 2025 and troughed at $2.5 million in Q2 2026.
- A 3-year average of $2.7 million and a median of $2.6 million in 2024 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles retreated 2.62% in 2025 and fell 14.75% in 2026, its largest moves.
- Over 3 years, Goodwill & Intangibles stood at $2.7 million in 2024, then decreased by 2.62% to $2.6 million in 2025, then declined by 5.21% to $2.5 million in 2026.
- The last three Goodwill & Intangibles figures came in at $2.5 million (Q2 2026), $2.6 million (Q4 2025), and $2.9 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 212.05 Bn | 198.06 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.76 Bn | 178.58 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.46 Bn | 124.61 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.66 Bn | 74.67 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.37 Bn | 1.37 Bn |
| 6 | Moderna | 54.69 Bn | 49.56 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn |
| 8 | Biogen | 31.46 Bn | 30.17 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.15 Bn | 30.15 Bn | 1.16 Mn |
| 10 | YD Bio | 29.02 Mn | 26.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.47 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Jun 30, 2025 | 2.90 Mn |
| Dec 31, 2024 | 2.68 Mn |